# reload+after+2024-01-21 20:46:44.150902
address1§711 Stewart Avenue
address2§Suite 200
city§Garden City
state§NY
zip§11530
country§United States
phone§215 345 0919
website§https://www.prophaselabs.com
industry§Diagnostics & Research
sector§Healthcare
longBusinessSummary§ProPhase Labs, Inc. engages in the development and commercialization of novel drugs, dietary supplements, and compounds in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It provides a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also offers contract manufacturing services, such as consumer product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, it is involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.
fullTimeEmployees§129
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Ted William Karkus', 'age': 64, 'title': 'Chairman & CEO', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 902200, 'exercisedValue': 0, 'unexercisedValue': 9933000}, {'maxAge': 1, 'name': 'Mr. Robert A. Morse Jr.', 'age': 48, 'title': 'CFO, Principal Financial Officer & Principal Accounting Officer', 'yearBorn': 1975, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Alice  Lioi', 'title': 'EVP & COO of ProPhase Diagnostics and ProPhase BioPharma', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Sergio  Miralles', 'title': 'Executive VP & Chief Information Officer of ProPhase Diagnostics', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Kamal  Obbad', 'title': 'Senior VP and Director of Sales & Marketing - Nebula Genomics', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jason  Karkus', 'title': 'President of ProPhase Diagnostics', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
exDividendDate§1653350400
payoutRatio§0.0
beta§-0.326
priceToSalesTrailing12Months§1.3668711
currency§USD
dateShortInterest§1702598400
forwardEps§-0.37
exchange§NCM
quoteType§EQUITY
shortName§ProPhase Labs, Inc.
longName§ProPhase Labs, Inc.
firstTradeDateEpochUtc§765466200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§072013b8-17d6-37c6-93e9-ffa6e6589859
gmtOffSetMilliseconds§-18000000
targetHighPrice§20.0
targetLowPrice§11.0
targetMeanPrice§15.5
targetMedianPrice§15.5
recommendationMean§2.0
recommendationKey§buy
numberOfAnalystOpinions§2
quickRatio§2.622
grossMargins§0.48763
ebitdaMargins§-0.15931
trailingPegRatio§None
